(Q77922758)
Statements
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia (English)
Bernstein SH
Fay J
Frankel S
Christiansen N
Baer MR
Jacobs C
Blosch C
Hanna R